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ABSTRACT: Plasmonic biosensing techniques employ metal nanostructures,
commonly gold (Au), often with biomolecules attached to their surfaces either
directly or via other linkers. Various surface chemistry methods based on dispersion
and covalent interactions are used to attach biomolecules to Au. As a result, when
immobilizing a molecule on a metal surface, quantitative estimates of binding
efficiency and stability of these surface chemistry methods are needed. Most prior
work to compare such methods deals with bulk/thin film configurations or spherical
nanoparticles, and very little is known about immobilization of biomolecules on
plasmonic nanostructures of different shapes. Besides, due to rapid advancement of
modern nanofabrication techniques, there is a growing need to determine an efficient
surface chemistry method for immobilization of biomolecules on nonspherical
plasmonic nanostructures. Previous comparison of immobilization methods on spherical Au nanoparticles has shown that
physical adsorption resulted in the highest concentration of immobilized antibodies. In our work, we conducted a similar study
and compared four representative Au surface functionalization methods as well as estimated how efficient these methods are at
attaching biomolecules to nonspherical plasmonic Au nanostructures. We estimated the concentration of immobilized antibody
that is specific to human C-reactive protein (anti-hCRP) by measuring the localized surface plasmon resonance (LSPR) shifts
after exposing the surface of Au nanostructures to the antibody. Our results differ from the previously reported ones since the
highest concentration of anti-hCRP was immobilized using 11-mercaptoundecanoic acid (MUA) chemistry. We demonstrated
that immobilized antibodies retained their stability and specificity toward hCRP throughout the immunoassay when diluted
hCRP or hCRP-spiked human serum samples were used. These findings have important implications for the fields of biosensing
and diagnostics that employ nonspherical plasmonic nanostructures since an overall performance of these devices depends on
efficient biomolecule immobilization.
Proteins are crucial for catalysis of metabolic reactions,defense against viruses and bacteria, signal transduction
within and between cells, transport of biomolecules, and cell
movement, to mention just a few functions.1−3 One strategy to
investigate biomolecules and their bioactivity is to examine
interactions between light (photons) and surrounding matter
(i.e., biological samples). These studies offer insights about
molecular function by evaluating changes in energy levels of
light upon sample exposure.4 One technique for studying
light−matter interactions is localized surface plasmon reso-
nance (LSPR) spectroscopy, which quantifies collective
resonance of free electrons on metal surfaces stimulated by
incident light when nanostructures are smaller in size than the
wavelength of the incoming light.5 Existing LSPR protein
detection and analytical systems are influenced by employed
surface chemistry method, which, in turn, is affected by the
substrate surface, shape, functional groups of immobilized
biomolecules, as well as by conditions of incubation steps.6−9
Poor immobilization may lead to changes in protein
conformation or structural modifications that reduce its overall
bioactivity.10,11 Therefore, optimization of surface chemistry
for maximum protein immobilization and retention of its
bioactive structure is critical.12,13 While there have been
comparative studies performed on individual Au nanoparticles,
our work builds upon this research by comparing biomolecule
immobilization methods using nonspherical plasmonic nano-
structures. Ciaurriz et al. compared immobilization of
biomolecules on spherical Au nanoparticles by means of
physical adsorption, methyl−PEG−thiol linkers, and hydrazine
dithiol linkers, and reported that simple adsorption resulted in
the most efficient functionalization of spherical Au nano-
particles.14 However, a similar study on functionalization of
nonspherical nanostructures is needed since it has been shown
that modifying aspect ratios and shapes of plasmonic
nanostructures increases their refractive index unit sensitivity
leading to improved levels of biosensing.15 This, in turn, leads
to development of both chemical and physical nanofabrication
techniques to produce nanostructures with increased variety of
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shapes and sizes.16 Thus, we compared performance of four
representative Au functionalization methods based on results
of an antibody immobilization on the surface of Au caps
positioned on silicon oxide nanocones.
Gold (Au) is the most commonly used noble metal in
plasmonic biosensing since it is chemically stable in air and
compatible with most biomolecules.17−19 Accordingly, we
chose Au nanostructures (AuNS) as a benchmark platform for
systematic studies of representative biomolecule immobiliza-
tion methods. Human C-reactive protein (hCRP) and its
respective antibody (anti-hCRP) were chosen as a model
protein system since hCRP with its antibody are regularly used
for protein binding assays.20 To immobilize anti-hCRP on
AuNS, we used four common Au functionalization techniques.
In the first method, proteins are attached to AuNS by means of
simple physical adsorption (referred to as the adsorption
method), performed by drop-casting a diluted protein solution
on the AuNS surface. Binding is based on dispersion forces
between biomolecules and the sensor surface. Although this
method is simple and quick, proteins are often immobilized in
random orientations and tend to deattach during changing of
incubation media or rinsing of the sensor surfaces.21 In the
second method, in microcontact printing (μCP method), the
antibody solution is used as ink and is first uniformly spread
over the poly(dimethylsiloxane) (PDMS) stamp, which is later
used to transfer proteins onto the substrate. This method
requires significantly less product and time and produces
uniform layers of primary antibodies.22 The third and fourth
immobilization methods utilize linkers that have thiol (−SH)
groups at one end and carboxyl groups (−COOH) at the other
end, such as 11-mercaptoundecanoic acid (MUA method) and
thiolated PEG acid linkers (HS−PEG−COOH method),
respectively. These methods attach biomolecules by means of
favorable interactions of Au with a sulfur atom (S) contained
in the thiolated ends of these linkers. This ensures orientation-
controlled immobilization of these linkers since they attach to
Au via their −SH ends and with their carboxyl ends pointing
away from the Au surface. Later, carboxyl groups of thiolated
linkers are activated to initiate binding of the biomolecules to
Au through these linkers. In our work, in addition to
introducing nonspherical Au nanostructures, we incorporate
an immobilization method based on self-assembly of thiolated
linkers with a longer uniform molecule length (MUA) than has
previously been reported by Ciaurriz et al.14 Au and S are both
large polarizable atoms that spontaneously form strong
covalent bonds with each other.23,24 For this purpose, the Au
surface is commonly coated with biomolecules having both
thermodynamically and sterically available thiol functional
groups.25,26 As a consequence, Au−S immobilization methods
are expected to produce more strongly linked and uniformly
oriented protein layers. However, a quantitative comparison of
these four immobilization techniques is needed since efficient
binding of molecules has a potential to improve sensitivity and
to lower both limits of detection (LOD) and quantification
(LOQ) of biosensing devices.
In this work, in addition to common immobilization
methods based on physical adsorption or thiolated PEG acid
linkers, we introduced a surface chemistry method with
controlled transfer of biomolecules onto a substrate, μCP,
and another immobilization method via longer thiolated
linkers with uniform chain length, 11-mercaptoundecanoic
acid (MUA). We used detected LSPR shifts to estimate the
concentration of anti-hCRP immobilized on AuNS using listed
surface chemistry methods in order to identify the most
efficient one. Eventually, we verified stability and specificity of
the immobilized antibody to ensure that anti-hCRP remains
bioactive and retains its specificity to hCRP; we also
demonstrated that antibodies immobilized via MUA method
can be efficiently used for hCRP sensing in human serum
samples.
■ EXPERIMENTAL SECTION
Materials. Silicon wafers coated with a SiO2 layer were
ordered from University Wafer (Massachusetts, U.S.A.). C-
Reactive protein, human serum (≥99%, CAS no. 9007-41-4)
was purchased from Merck Millipore (Tokyo, Japan). Human
CRP antibody (MAB 17073), human CRP biotinylated
antibody (BAM 17072), and recombinant human interleu-
kin-6 protein (IL-6, 206-IL/CF) were purchased from R&D
Systems (Minnesota, U.S.A.). Tween20 (CAS no. 9005-64-5),
bovine serum albumin (BSA, ≥ 96%, CAS no. 9005-64-5),
phosphate buffer saline (PBS, MFCD 00131855), ethanol
(95%, CAS no. 64-17-5), 11-mercaptoundecanoic acid (MUA,
98%, CAS no. 71310-21-9), 6-mercapto-1-hexanol (MCH,
97%, CAS no. 1633-78-9), 1-ethyl-3-(3-(dimethylamino)-
propyl)carbodiimide hydrochloride (EDC, CAS no. 25952-
53-8), and N-hydroxysuccinimide (NHS, 98%, CAS no. 6066-
82-6) were purchased from Sigma-Aldrich (Tokyo, Japan).
The PDMS elastomer kit was purchased from Dow Sylgard
184 (Wisconsin, U.S.A.). Thiol PEG acid (HS−PEG−COOH,
MW 5000, PG2-CATH-5K-2) and thiol PEG thiol (HS−
PEG−SH, MW 2000, PG2-TH-2K) were ordered from e-
Nacalai (Tokyo, Japan). Human CRP-spiked human serum
(ST-8007X4) was provided by LSI Medience Corporation
(Tokyo, Japan). Deionized (DI) water from an 18.2 MΩ·cm−1
Milli-Q Integral 3 water purification system (Millipore,
Germany) was used as a rinsing solution.
Device Fabrication and Measurement Setup. Silicon
wafers with 500 nm of thermal oxide on top were coated with 4
nm of atomic Au using an e-beam evaporator (PLASSYS
Bestek, France), followed by thermal dewetting at 560 °C for
3.5 h. Next, substrates were placed into an inductively coupled
plasma−chemical vapor deposition (ICP−CVD, Oxford
Instruments Plasma Technology, England) system (SF6, 45
sccm) for 5 min. The resulting nanostructures were shaped as
SiO2 nanocones coated with spherical AuNS (Figure 1).
27
Sensor Functionalization. In all experiments, anti-hCRP
was diluted to 100 ng/mL in 0.01 M PBS. Between incubation
steps, the sensor surface was first rinsed with wash buffer (0.01
M PBS plus 0.05% Tween20 detergent), and then with Milli-Q
water. All functionalized sensor surfaces were blow-dried with
compressed N2 gas, and UV−vis signals were detected using a
UV−vis spectrophotometer (Ocean Optics, Japan).
Physical Adsorption Methods. In the simple adsorption
method (adsorption), substrates were incubated in anti-hCRP
solution for 2 h at 4 °C on a shaker. In the μCP method, a
PDMS stamp was first inked with 20 μL of 100 ng/mL anti-
hCRP antibody solution for 10 min under an O2 plasma
activated coverslip (Figure S1).28 Next, the stamp was rinsed
with 0.01 M PBS and 18.2 MΩ·cm−1 Milli-Q water, dried with
N2, and contacted with the surface of Au-coated silica
nanocones for 2 s.
Covalent-Linking Methods. For the MUA method, the
sensors were first incubated (overnight, RT) in 1 M/9 M
solution of MUA/MCH, and then in 1 mM MCH (1 h,
RT).29,30 Then, the −COOH ends of MUA were activated via
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carboxyl-to-amine cross-linking by incubating thiolated sub-
strates in a 4 M/1 M mixture of EDC and NHS (15 min, RT),
followed by anti-hCRP for 2 h at 4 °C on a shaker.31 In the
HS−PEG−COOH immobilization technique, substrates were
incubated in an 15/85 mixture of HS−PEG−COOH/HS−
PEG−SH (overnight, RT), followed by backfilling with 1 μM
HS−PEG solution (1 h, RT) and further activation of
−COOH using EDC/NHS (4 M/1 M, 15 min, RT) chemistry
and incubation in anti-hCRP solution for 2 h at 4 °C.32
Negative Control Systems. For the first control system, a
bare Au-coated SiO2 substrate was blocked with 0.01% BSA,
followed by incubation in 100 ng/mL hCRP (1.5 h, 4 °C), and
then in 100 ng/mL biotinylated anti-hCRP (1.5 h, 4 °C). For
the second control, a fully BSA-coated sensor was directly
incubated in 100 ng/mL solution of biotinylated anti-hCRP (2
h, 4 °C).
Stability Analysis and Sensor Specificity. To identify
whether immobilized anti-hCRP was bioactive, sensor surfaces
were sequentially incubated in 0.01% BSA solution (2 h, RT),
100 ng/mL hCRP solution (2 h, 4 °C), and 100 ng/mL
biotinylated anti-hCRP (1.5 h, 4 °C). For devices’ specificity
analysis, sensors were incubated in 100 ng/mL solution of
nonspecific IL-6 (2 h, 4 °C) instead of hCRP. Lastly, LOD and
LOQ of the sensors were identified by incubating devices in
five different concentrations of hCRP (100 pg/mL, 1 ng/mL,
10 ng/mL, 100 ng/mL, and 1 μg/mL).
■ RESULTS AND DISCUSSION
Immobilization Results. The UV−vis spectra of AuNS
surfaces before and after anti-hCRP immobilization were
acquired using the measurement setup shown in Figure 2. The
maximum peak values of the recorded UV−vis spectra
correspond to the maximum λLSPR that indicates the resonant
wavelength at which AuNS surface electrons oscillate. The
exact maximum λLSPR value varies depending on the shape,
size, aspect ratio, and material composition of the nanostruc-
tures.33−35 For instance, it has been demonstrated that
increasing the size and aspect ratio of nanostructures
commonly makes surface electrons resonate at a lower
frequency, i.e., causes a red shift in λLSPR.
36−38 Gans’ theory
states the relationship between resonant wavelength λLSPR and
all other important parameters, such as aspect ratio of
nanostructures, dipole moments, and dielectric constants of
metal and surrounding media:
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where N is the number of particles and V is the volume of each
particle, εm is the dielectric constant of the medium, γ is the
extinction coefficient, ε1 and ε2 are the real and complex parts
of the material’s dielectric function. Pj is the depolarization
constant that depends on aspect ratio of the nanostruc-
tures.37,39 Therefore, if all parameters are kept constant except
for the dielectric constant of the medium εm, we can calculate
changes of the dielectric constant and relate that to fluctuations
in the refractive index n of the medium since εm = n + ik
2,
where n is the refractive index and k is the propagation
wavevector.40 Since λLSPR has a linear dependence on n, shifts
in λLSPR are commonly used to detect shifts in n of a sample
and, as a consequence, to estimate concentrations of various
analytes.41 Provided that the only parameter changing between
the measurements is concentration of an analyte, the detected
ΔλLSPR is related to the quantity of an analyte in the proximity
of the nanostructures’ surface.36,42 That is, binding of
biomolecules to a nanostructure shifts λLSPR so that the
concentration of the analyte can be calculated precisely (Figure
3).43 Therefore, in our work, ΔλLSPR measured after incubation
of AuNS in anti-hCRP depends on the concentration of
primary antibody attached to AuNS. This shift was used to
estimate the primary antibody immobilization efficiency of the
selected four representative Au surface chemistry methods.
In this context, immobilization efficiency is related to the
number of anti-hCRP molecules that remain attached to the
sensor surface after incubation of AuNS substrate in the
primary antibody solution and rinsing it with PBS and Milli-Q
water. Immobilization efficiency is related to the percentage of
biomolecules attached to the metal surface, which can be
expressed as follows:
Figure 1. SEM image (1400× magnification using an FEI Quanta 250
FEG) of Au-capped SiO2 nanocones prepared by deposition of 4 nm
of Au on silicon wafers coated with 500 nm of thermal oxide, followed
by 3.5 h of thermal dewetting at 560 °C and SF6 etching (5 min).
Scale bar = 100 nm.
Figure 2. Measurement setup: tungsten halogen light source (HL-
2000-HP-FHSA Ocean Optics, Japan) emits light on the sample
surface that reflects back to the detector, and then to the spectrometer
(USB4000-UV-VIS-ES Ocean Optics, Japan); recorded signal is
visualized as a UV−vis spectrum from 200 to 850 nm range and is
analyzed using SpectraSuite spectrometer operating software (Ocean
Optics, Japan).
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A surface chemistry method that immobilizes the largest
concentration of anti-hCRP was expected to display the largest
ΔλLSPR and, as a consequence, the highest immobilization
efficiency. Four immobilization methods that we analyzed
resulted in different values of ΔλLSPR which implies that a
different number of the primary antibody molecules was
attached to AuNS although the same initial concentration of
anti-hCRP was used in each method. Therefore, these methods
are characterized by different immobilization efficiencies (eq
2) and can be compared to each other.
A wavelength shift caused by immobilization of anti-hCRP
on a bare AuNS substrate is demonstrated in Figure 4a as a
difference between two UV−vis spectra measured before and
after incubation of AuNS in anti-hCRP solution. These
differences in the λLSPR values from before and after antibody
immobilization are then collected from repetitive measure-
ments and plotted in Figure 4b with their standard deviations
(see Table 1). To find if these methods were significantly
different from each other, we compared their mean values by
applying the analysis of variance (ANOVA) statistical test.
According to ANOVA results, p- and F-values were equal to
0.001 and 10.2 for selected value of α = 0.05, respectively. On
the basis of the p-value being smaller than 0.05 and the F-value
being greater than F-critical (F-critical = 3.24), the Null
hypothesis can be rejected since at least two immobilization
methods have significantly different mean values. Two-sample t
tests and p-value comparisons can be found in Table S1.
Immobilization of anti-hCRP using MUA linkers led to the
largest ΔλLSPR with the smallest standard deviation (13.60 ±
1.02 nm), implying that this Au functionalization method
resulted in the highest concentration of immobilized anti-
hCRP and therefore had the highest immobilization efficiency
(eq 2). Thiol, −SH, functional groups present on MUA
molecules spontaneously form covalent bonds with AuNS due
to high affinity between Au and S atoms.44,45 Moreover,
proteins immobilized using covalent interactions are expected
to stay attached longer due to higher resistance to washing and
blow-drying of the sensor surface. Adsorption and μCP, on the
other hand, are based on weak dispersion interactions between
AuNS and the primary antibody, which is why they were found
to have lower immobilization efficiency (see Figure 4b and
Table 1). In addition, since formation of dispersion forces is
highly dependent on the substrate property, the nonspherical
shape of AuNS is directly related to nonuniformity of the
sensor surface. Highly variable μCP results are explained by the
fact that transfer of anti-hCRP from the PDMS stamp to AuNS
caused damage to the sensor surfaces. Fragility of fabricated
nanostructures was problematic since direct contact between
the PDMS stamp and the sensor surface removed some of the
nanostructures. Removed nanostructures could be later
observed on the surface of the PDMS stamp (Figure S2).
Since the sensor surface is composed of an array of closely
located LSPR nanostructures, the final LSPR signal detected
from the sensor surface is affected by plasmonic coupling
between nanostructures in close proximity to each other.
Consequently, removal of a small patch of AuNS due to a
direct contact with the PDMS stamp caused a unique
modification of the entire sensor surface in each case. This,
as a result, leads to poorly reproducible immobilization results
by using the μCP method since sensor surfaces were different
after stamping the AuNS in every replication of ΔλLSPR
measurements. On the basis of these results, the MUA method
Figure 3. Electrons on the surface of a bare Au nanostructure
resonate at a specific λLSPR (before binding); this λLSPR varies
depending on the shape, size, and composition of the nanostructures
as well as being affected by the environment surrounding these
nanostructures. Binding of biomolecules changes the refractive index
of the surrounding media around these nanostructure and, as a
consequence, shifts λLSPR at which surface electrons resonate (after
binding).
Figure 4. (a) UV−vis spectra recorded from bare Au nanostructures (red) and after immobilization of 100 ng/mL anti-hCRP on AuNS (green):
functionalization of AuNS with anti-hCRP made the whole spectrum shift to the right. (b) ΔλLSPR (nm) averaged over eight runs of immobilization
of anti-hCRP using adsorption, μCP, MUA, and HS−PEG−COOH linkers. The MUA immobilization method gave the largest ΔλLSPR with the
smallest standard deviation (13.60 ± 1.02 nm) (i.e., had the highest immobilization efficiency).
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leads to the highest concentration of immobilized anti-hCRP
(i.e., the highest immobilization efficiency). Thus, the MUA
immobilization method is recommended for attaching of anti-
hCRP to the nonspherical AuNS surfaces.
Stability Analysis. Efficient initial immobilization of anti-
hCRP on AuNS does not always prevent deattachment of
molecules during washing, transferring media, and measuring
UV−vis signals. Therefore, to perform a complete stability
analysis, standard sandwich-type protein detection assays were
performed (Figure 5).46 In this context, stability refers to the
duration of the antibody attachment onto the sensor surface
when the latter is subjected to protein binding immunoassay
involving repetitive changes of the incubation media, rinsing,
and blow-drying of the sensor surface.
To minimize false positive measurements as well as to
prevent biofouling of molecules, we introduced two negative
control systems using 0.01% BSA blocking buffer.47 These
control systems were performed by initially coating the entire
sensor surface with 0.01% BSA solution. Provided that the
blocking buffer is active, the sensor surface was expected to be
fully coated with BSA which would prevent subsequent linking
of biomolecules (i.e., hCRP and biotinylated anti-hCRP). In
both cases, BSA-blocked sensors after incubation in protein
solutions of hCRP and biotinylated anti-hCRP resulted in
negligible ΔλLSPR (see Figure 6 and Table 2) suggesting that
BSA successfully blocks the sensor surface and averts
nonspecific binding of both antigen and biotinylated antibody
to AuNS. Therefore, BSA solution was proven to be effective at
preventing false positive signals and, for further stability
analysis of sensors functionalized with anti-hCRP, sensors were
then incubated in BSA, hCRP, and biotinylated anti-hCRP.
To test the stability of anti-hCRP immobilization, anti-
hCRP-functionalized sensors were sequentially incubated in
0.01% BSA solution, 100 ng/mL hCRP, and 100 ng/mL
biotinylated anti-hCRP. Assuming that bare Au patches were
blocked with BSA, ΔλLSPR detected after introducing hCRP
and biotinylated anti-hCRP was explained by binding of hCRP
to anti-hCRP and of biotinylated anti-hCRP to hCRP (Table
3).
The wavelength shifts measured from substrates function-
alized with anti-hCRP bound through physical adsorption were
2.00, 2.25, and −3.00 nm after binding of BSA, hCRP, and
biotinylated anti-hCRP, respectively. This indicates that,
although both blocking buffer and hCRP bound efficiently,
the final incubation in biotinylated anti-hCRP induced loss of
biomolecules from the sensor surface. A primary source of
biomolecule loss originates from rinsing of substrates between
incubation steps and UV−vis measurements, which is observed
as a blue shift since these antibodies are heavy in mass and
overall neutrally charged. Thus, anti-hCRP was not strongly
bound to AuNS, which was anticipated since dispersion forces
are based on weak intermolecular interactions. Table 3 shows
that substrates functionalized with μCP gave the most
scattered results: 12.29, 2.25, and −2.88 nm. Like the
adsorption method, μCP is based on weak dispersion forces,
which explains negative ΔλLSPR after incubation in biotinylated
anti-hCRP. In addition, aforementioned damage to the sensor
surface by the PDMS stamp contributed to dispersion of the
detected signals. Immobilization methods using both MUA
(1.60, 5.20, 6.80 nm) and HS−PEG−COOH (2.00, 1.40, 2.60
nm) linkers resulted mostly in red shifts of ΔλLSPR; however,
the MUA method generated the most reproducible measure-
ments. This observation can be explained by the uniform
length of MUA linkers and strong Au−S covalent interactions
that efficiently hold anti-hCRP on the AuNS surface.48 HS−
PEG−COOH linkers are commonly characterized by average
weight since the length of individual molecules varies.49
Various lengths of individual PEG linkers lead to slightly more
scattered measurements when compared to uniformly long
MUA linkers. One possible explanation for this is that, since
PEGylated linkers are not equal in length, the extinction
coefficient around each nanostructure is somewhat different,50
whereas MUA molecules consist of 11 −CH2− units ensuring
a uniform distance between anti-hCRP and AuNS. In addition,
an adequate distance between the biomolecule and the
substrate surface assures that this molecule retains its overall
shape and conformation. Optimal distance between the
nanostructure surface and the immobilized biomolecule varies
depending on a number of parameters including size, shape,
and dielectric constants of both the nanostructure and the
biomolecule.51,52 According to our findings, anti-hCRP bound
to AuNS via MUA linkers remains bioactive, which implies
that the spacing between the antibody and AuNS is sufficient.
Since this method resulted in the highest ΔλLSPR after exposing
anti-hCRP-coated AuNS to hCRP, and later to biotinylated
anti-hCRP, we concluded that this immobilization strategy
leads to the most efficient immobilization of anti-hCRP and
ensures these antibodies remain attached to the sensor surface
throughout a sandwich-type immunoassay.
In addition, we tested HS−PEG−COOH and MUA
coverage uniformity by measuring the mean fluorescence
intensity of sensors functionalized with fluorescent streptavidin
dye. Figures S3 and S4 show confocal microscopy images of
these sensor surfaces and normalized fluorescence intensity
plots, respectively. We found that streptavidin dye immobilized
via MUA surface chemistry had higher fluorescence intensity
(i.e., higher concentration) and smaller standard deviation (i.e.,
Table 1. ΔλLSPR Detected after Incubation in a 100 ng/mL Solution of anti-hCRP (2 h, 4 °C)
immobilization method adsorption μCP MUA HS−PEG−COOH
ΔλLSPR (nm) 11.8 ± 1.1 12.0 ± 3.3 13.6 ± 1.0 5.33 ± 2.9
Figure 5. Functionalization of Au nanostructures with anti-hCRP was
followed by incubation in 0.01% BSA (2 h, RT), 100 ng/mL hCRP (2
h, 4 °C), and biotinylated anti-hCRP (anti-hCRP*, 1.5 h, 4 °C). UV−
vis spectra were recorded after each protein immobilization step.
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better uniformity). As a consequence, the MUA immobiliza-
tion method has the most reliable results in the efficiency and
stability analysis tests. Although the MUA immobilization
method resulted in the most reproducible measurements, it has
not been previously quantitatively compared to other Au
surface functionalization methods. Therefore, despite of this
method being quite time-consuming, it is recommended for
immobilization of biomolecules on nonspherical plasmonic Au
nanostructures.
Sensor Specificity, LOD, and LOQ. Although the MUA
method efficiently binds anti-hCRP to AuNS and ensures the
antibody stays attached to the sensor surface throughout the
immunoassay, it does not necessarily guarantee that anti-hCRP
remains specific solely to its antigen, hCRP. To test its
specificity, after treating the surface of the anti-hCRP-coated
substrate with 0.01% BSA, 100 ng/mL IL-6 was introduced
onto the sensor surface instead of its specific hCRP. Incubation
of anti-hCRP-coated AuNS substrates in IL-6 resulted in
negligible ΔλLSPR, suggesting that anti-hCRP immobilized
using MUA method retains its specificity to hCRP (see Figure
7 and Table 4).
The final test performed to characterize the sensor surface
functionalized with anti-hCRP using the MUA method was
estimation of its LOD and LOQ. Sensors with anti-hCRP
attached to their surfaces were incubated in five different
concentrations of hCRP (Figure 8).
Figure 6. (a) UV−vis spectra recorded from bare Au nanostructures (red), after blocking the surface with BSA (blue), after incubation in hCRP
(purple), and after incubation in biotinylated anti-hCRP (teal). (b) Control 1: ΔλLSPR (nm) detected after incubation of BSA-blocked bare
substrate in hCRP and biotinylated anti-hCRP. (c) UV−vis spectra recorded from bare Au nanostructures (red), after blocking the surface with
BSA (blue), and after incubation in biotinylated anti-hCRP (teal). (d) Control 2: ΔλLSPR (nm) after incubation of BSA-blocked bare substrate in
biotinylated anti-hCRP.
Table 2. ΔλLSPR Measured in Negative Control Systems after
Exposing BSA-Blocked AuNS to hCRP, Biotinylated anti-
hCRP (anti-hCRP*) in Control 1, and Only Biotinylated
anti-hCRP (anti-hCRP*) in Control 2
ΔλLSPR (nm) BSA hCRP anti-hCRP*
control 1 15.8 ± 1.6 −0.80 ± 1.2 −0.20 ± 0.8
control 2 21.25 ± 2.2 0.0 ± 1.4
Table 3. ΔλLSPR Detected after Blocking with 0.01% BSA, Incubation in 100 ng/mL hCRP, and 100 ng/mL Biotinylated anti-
hCRP (anti-hCRP*)a
ΔλLSPR (nm) adsorption μCP MUA HS−PEG−COOH
BSA 2.00 ± 2.35 12.29 ± 6.61 1.60 ± 1.36 2.00 ± 3.52
hCRP 2.25 ± 5.31 2.25 ± 2.77 5.20 ± 1.83 1.40 ± 1.02
anti-hCRP* −3.00 ± 4.06 −2.88 ± 4.91 6.80 ± 1.17 2.60 ± 2.42
aSensor functionalization using MUA linkers leads to the highest hCRP and anti-hCRP immobilization results.
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To calculate limits of detection and quantification of the
functionalized sensor surface, we used a standard approach by
plotting dependence of ΔλLSPR on the measured concentration
of hCRP and calculated LOD and LOQ according to the
standard formulas:53
i
k
jjjjj
y
{
zzzzzLOD
standard error
slope
3.3=
(3)
i
k
jjjjj
y
{
zzzzzLOQ
standard error
slope
10=
(4)
Figure 8 demonstrates a relationship between ΔλLSPR (nm)
and concentration of hCRP in nanograms per milliliter. Since
only the first four data points were in a linear regime, we
plotted a standard addition line as a calibration curve by using
those points and got the following equation: y = 0.0561x +
0.1933, where slope = 0.0561 ng/mL indicates the sensitivity
of the fabricated sensors. Standard error was calculated using
the STEYX function in Excel and was found to be equal to
0.6967 ng/mL. By inserting these values, we calculated LOD
and LOQ according to eqs 3 and 4 and found them to be equal
to 41.0 and 124.2 ng/mL, respectively. Calculated limits are
comparable to those of previously reported studies when Au
nanoparticles were used for biosensing of hCRP (e.g., LOD =
19 ng/mL)54 and are significantly lower than the working
protein concentrations, which is why resolution of measured
signals can be justified.55
Lastly, to test the efficiency of the MUA immobilization
method for biosensing applications, we performed an
immunoassay with anti-hCRP as a primary antibody and
human serum spiked with 100 ng/mL hCRP as an antigen.
Mean ΔλLSPR after introducing the hCRP-spiked human serum
sample was calculated to be 4.86 ± 0.64, whereas mean ΔλLSPR
after incubation in pure 100 ng/mL hCRP was equal to 5.20 ±
1.83 (p-value = 0.46, α = 0.05). Both hCRP-spiked human
serum and pure hCRP samples display similar wavelength
shifts, implying that MUA surface chemistry is an efficient
method for immobilizing biomolecules on nonspherical Au
nanostructures for complex biological sample sensing applica-
tions.
■ CONCLUSIONS
Herein, we compared four representative surface chemistry
methods exploited for immobilization of biomolecules on Au
nanostructures and estimated effect of nonspherical shapes of
nanostructures for LSPR biosensing applications. Protein
immobilization efficiency was estimated based on the λLSPR
shifts before and after incubation of AuNS in anti-hCRP.
According to our findings, when nonspherical plasmonic Au
nanostructures are employed for LSPR sensing, binding of
Figure 7. Specificity analysis: (a) UV−vis spectra recorded from bare Au nanostructures (red), after introducing MUA linkers (pink), after
incubating in anti-hCRP (green), further blocking with BSA (blue), incubating in nonspecific IL-6 (purple), and biotinylated anti-hCRP (teal). (b)
ΔλLSPR (nm) averaged over eight runs of incubation of substrates functionalized with anti-hCRP in 100 ng/mL IL-6; anti-hCRP immobilized on Au
nanostructures using MUA linkers did not bind to nonspecific IL-6 or biotinylated anti-hCRP (anti-hCRP*).
Table 4. ΔλLSPR after Functionalization of AuNS with 100 ng/mL anti-hCRP Using the MUA Method, Later Incubated in
0.01% BSA, 100 ng/mL Nonspecific IL-6 (1.5 h, 4 °C), and 100 ng/mL Biotinylated anti-hCRP (anti-hCRP*; 1.5 h, 4 °C)
incubation step MUA anti-hCRP BSA IL-6 anti-hCRP*
ΔλLSPR (nm) 3.00 ± 1.3 14.1 ± 1.1 −0.71 ± 0.9 −0.44 ± 0.8 0.29 ± 0.7
Figure 8. LOD calculations: sensors functionalized with anti-hCRP
were incubated in five different concentrations of hCRP (100 pg/mL,
1 ng/mL, 10 ng/mL, 100 ng/mL, and 1 μg/mL). The mean values of
ΔλLSPR were plotted against hCRP concentrations, and LOD was
found to be equal to 41.0 ng/mL.
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proteins via MUA linkers gives the most efficient and
reproducible antibody immobilization results. Furthermore,
anti-hCRP bound to the sensor surface via MUA linkers
retained its specificity toward hCRP, accurately detected hCRP
in human serum, and gave negligible ΔλLSPR after incubation in
a nonspecific antigen, IL-6. Finally, LOD and LOQ of sensors
functionalized using the present surface chemistry were found
to be sufficiently low, 41.0 and 124.2 ng/mL. Overall, MUA
surface chemistry is recommended for binding of biomolecules
to nonspherical plasmonic Au nanostructures, and thus, our
work reveals critical new information for efficient immobiliza-
tion of biomolecules important for reliable plasmonic
biosensing purposes that leads to more sensitive molecule
detection and, as a consequence, to more accurate diagnostics.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.anal-
chem.9b03780.
Schematic explanation of the μCP mechanism using a
PDMS stamp and real images of the PDMS stamps
before and after contacting with the AuNS surface,
immobilization efficiency analysis supported by adding
the mean fluorescence data for HS−PEG−COOH and
MUA modified substrates, and ANOVA and two-sample
t tests for estimation of statistical significance of the
acquired data (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: amy.shen@oist.jp.
ORCID
Ainash Garifullina: 0000-0002-9330-0605
Amy Q. Shen: 0000-0002-1222-6264
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
We acknowledge financial support from the Okinawa Institute
of Science and Technology Graduate University (OIST) with
subsidy funding from the Cabinet Office, Government of
Japan. In addition, the authors thank Dr. Nikhil Bhalla who
provided insight and expertise that assisted the research and
Ms. Shivani Sathish for great assistance with methodology.
■ REFERENCES
(1) Freeman, S.; Sharp, J. C.; Harrington, M. Biological Science;
Prentice Hall: Upper Saddle River, NJ, 2002; Vol. 1.
(2) Stewart, D. E.; Sarkar, A.; Wampler, J. E. J. Mol. Biol. 1990, 214,
253−260.
(3) Alberts, B.; Bray, D.; Hopkin, K.; Johnson, A.; Lewis, J.; Raff, M.;
Roberts, K.; Walter, P. Essential Cell Biology; Garland Science: New
York, 2013.
(4) Prasad, P. N. Introduction to Biophotonics; John Wiley & Sons:
Hoboken, NJ, 2004.
(5) Anker, J. N.; Hall, W. P.; Lyandres, O.; Shah, N. C.; Zhao, J.;
Van Duyne, R. P. Nanoscience And Technology: A Collection of Reviews
from Nature Journals; World Scientific: Singapore, 2010; pp 308−319.
(6) Rao, V. S.; Srinivas, K.; Sujini, G. N.; Kumar, G. N. Int. J.
Proteomics 2014, 2014, 1−12.
(7) Arkin, M. R.; Wells, J. A. Nat. Rev. Drug Discovery 2004, 3, 301.
(8) Aschenbrenner, D.; Pippig, D. A.; Klamecka, K.; Limmer, K.;
Leonhardt, H.; Gaub, H. E. PLoS One 2014, 9, e115049.
(9) Liu, Y.; Yu, J. Microchim. Acta 2016, 183, 1−19.
(10) Rao, S. V.; Anderson, K. W.; Bachas, L. G. Microchim. Acta
1998, 128, 127−143.
(11) Liu, Y.; Zhu, Z.; Wang, C.; Gao, R.; Yang, X.; Liu, S. Analyst
2019, 144, 2130−2137.
(12) Niu, L.; Zhang, N.; Liu, H.; Zhou, X.; Knoll, W. Biomicrofluidics
2015, 9, 052611.
(13) Aube,́ A.; Campbell, S.; Schmitzer, A. R.; Claing, A.; Masson, J.-
F. Analyst 2017, 142, 2343−2353.
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